Yield10 Bioscience

About:

Yield10 Bioscience develops crop yield improvement solutions using advanced genetic engineering and synthetic biology techniques.

Website: https://www.yield10bio.com

Twitter/X: Yield10Bio

Top Investors: US Department of Energy, U.S. Department of Agriculture, Oracle Investment Management Inc., Jack W. Schuler Living Trust, Jack Schuler

Description:

Yield10 Bioscience is a biotechnology company that specializes in developing innovative crop yield improvement solutions using advanced genetic engineering and synthetic biology techniques. The company focuses on creating proprietary traits and technologies that can enhance the productivity and nutritional profile of various crops, with an emphasis on oilseed crops and other specialty crops. Yield10 Bioscience employs cutting-edge biotechnological tools to develop and test their plant traits and technologies. This includes utilizing techniques like gene editing, genome engineering, and metabolic engineering to introduce specific genetic modifications into plants that can lead to desired traits.

Total Funding Amount:

$125M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Woburn, Massachusetts, United States

Founded Date:

1992-01-01

Founders:

Anthony J. Sinskey, Oliver P. Peoples

Number of Employees:

11-50

Last Funding Date:

2023-08-11

IPO Status:

Public

Industries:

© 2025 bioDAO.ai